PubMed (GeneRIF) for id: 6752

Year	Number of Results
2001	2
2002	6
2003	7
2004	7
2005	5
2006	6
2007	7
2008	14
2009	16
2010	16
2011	6
2012	9
2013	8
2014	10
2015	20
2016	9
2017	4
2018	5
2019	6
2020	3
2021	10
2022	4
2023	5
2024	2

1

Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.

Kim JY, Kim J, Kim YI, Yang DH, Yoo C, Park IJ, Ryoo BY, Ryu JS, Hong SM. Kim JY, et al. Sci Rep. 2024 Feb 19;14(1):4047. doi: 10.1038/s41598-024-54599-4. Sci Rep. 2024. PMID: 38374188 Free PMC article.

2

Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.

Fan S, Zheng H, Zhan Y, Luo J, Zang H, Wang H, Wang W, Xu Y. Fan S, et al. Crit Rev Oncol Hematol. 2024 Jan;193:104223. doi: 10.1016/j.critrevonc.2023.104223. Epub 2023 Nov 29. Crit Rev Oncol Hematol. 2024. PMID: 38036157 Review.

3

Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment.

Gillis A, Zheng-Pywell R, McLeod C, Wang D, Ness JM, Guenter R, Whitt J, Prolla TA, Chen H, Gonzalez ML, Rose B, Lloyd RV, Jaskula-Sztul R, Lin D. Gillis A, et al. Mod Pathol. 2023 Dec;36(12):100332. doi: 10.1016/j.modpat.2023.100332. Epub 2023 Sep 15. Mod Pathol. 2023. PMID: 37716507

4

Epigenetic regulation of SST₂ expression in small intestinal neuroendocrine tumors.

Klomp MJ, Refardt J, van Koetsveld PM, Campana C, Dalm SU, Dogan F, van Velthuysen MF, Feelders RA, de Herder WW, Hofland J, Hofland LJ. Klomp MJ, et al. Front Endocrinol (Lausanne). 2023 May 8;14:1184436. doi: 10.3389/fendo.2023.1184436. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37223009 Free PMC article.

5

Role of Somatostatin Receptor 2 in Nonfunctional Pancreatic Neuroendocrine Tumors: Clinicopathological Analysis of 223 Cases and Whole Exome Sequencing of a Multifocal Case.

Hu HF, Hu YH, Xu XW, Ye Z, Lou X, Zhang WH, Chen XM, Zhang Y, Yu XJ, Gao HL, Xu JY, Ji SR. Hu HF, et al. Pancreas. 2022 Nov-Dec 01;51(10):1404-1410. doi: 10.1097/MPA.0000000000002199. Pancreas. 2022. PMID: 37099786

6

Somatostatin receptor 2 in 10 different types of human non-neoplastic gastrointestinal neuroendocrine cells.

Watanabe H, Fujishima F, Unno M, Sasano H, Suzuki T. Watanabe H, et al. Pathol Res Pract. 2023 Apr;244:154418. doi: 10.1016/j.prp.2023.154418. Epub 2023 Mar 18. Pathol Res Pract. 2023. PMID: 36989844

7

Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.

Fischer A, Kloos S, Maccio U, Friemel J, Remde H, Fassnacht M, Pamporaki C, Eisenhofer G, Timmers HJLM, Robledo M, Fliedner SMJ, Wang K, Maurer J, Reul A, Zitzmann K, Bechmann N, Žygienė G, Richter S, Hantel C, Vetter D, Lehmann K, Mohr H, Pellegata NS, Ullrich M, Pietzsch J, Ziegler CG, Bornstein SR, Kroiss M, Reincke M, Pacak K, Grossman AB, Beuschlein F, Nölting S. Fischer A, et al. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2676-2685. doi: 10.1210/clinem/dgad166. J Clin Endocrinol Metab. 2023. PMID: 36946182 Free PMC article.

8

Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment.

Wang A, Yuan Y, Chu H, Gao Y, Jin Z, Jia Q, Zhu B. Wang A, et al. Pathol Oncol Res. 2022 Feb 21;28:1610196. doi: 10.3389/pore.2022.1610196. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35264912 Free PMC article.

9

Diagnostic Utility of Somatostatin Receptor 2A Immunohistochemistry for Tumor-induced Osteomalacia.

Lee S, Hong N, Shin S, Kim SI, Yun M, Kim SK, Rhee Y. Lee S, et al. J Clin Endocrinol Metab. 2022 May 17;107(6):1609-1615. doi: 10.1210/clinem/dgac096. J Clin Endocrinol Metab. 2022. PMID: 35184184

10

The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma.

Fodi C, Skardelly M, Hempel JM, Hoffmann E, Castaneda S, Tabatabai G, Honegger J, Tatagiba M, Schittenhelm J, Behling F. Fodi C, et al. Neurosurg Rev. 2022 Aug;45(4):2671-2679. doi: 10.1007/s10143-021-01651-w. Epub 2021 Oct 2. Neurosurg Rev. 2022. PMID: 34601710 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

168 results

Results by year